Notice of Prospective Grant of Exclusive Patent License, 12596 [E7-4865]

Download as PDF 12596 Federal Register / Vol. 72, No. 51 / Friday, March 16, 2007 / Notices It was not possible to publish this notice 15 days in advance of the meeting date because of internal processing delays. DEPARTMENT OF COMMERCE Dated at Washington, DC, March 13, 2007. Ivy L. Davis, Acting Chief, Regional Programs Coordination Unit. [FR Doc. E7–4837 Filed 3–15–07; 8:45 am] Notice of Prospective Grant of Exclusive Patent License National Institute of Standards and Technology BILLING CODE 6335–01–P COMMISSION ON CIVIL RIGHTS Agenda and Notice of Public Meeting of the Illinois Advisory Committee Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights and the Federal Advisory Committee Act, that a planning meeting with briefing of the Illinois Advisory Committee will convene at 1 p.m. and adjourn at 5 p.m. on Thursday, March 22, 2007, at 55 W. Monroe Street, Fifth Floor Conference Room, Chicago, Illinois 60603. The purpose of the planning meeting with briefing is to conduct an orientation and ethics training for new members, plan future activities, and have a briefing on religious discrimination in prisons. Persons desiring additional information, or planning to present a statement to the Committee, should contact Constance M. Davis, Regional Director of the Midwestern Regional Office, 312–353–8311 (TDD 312–353– 8362). Hearing impaired persons who will attend the meeting and require the services of a sign language interpreter should contact the Regional Office at least ten (10) working days before the scheduled date of the meeting. The meeting will be conducted pursuant to the provisions of the rules and regulations of the Commission and the Federal Advisory Committee Act. It was not possible to publish this notice 15 days in advance of the meeting date because of internal processing delays. sroberts on PROD1PC70 with NOTICES Dated at Washington, DC, March 13, 2007. Ivy L. Davis, Acting Chief, Regional Programs Coordination Unit. [FR Doc. E7–4838 Filed 3–15–07; 8:45 am] BILLING CODE 6335–01–P VerDate Aug<31>2005 15:24 Mar 15, 2007 Jkt 211001 National Institute of Standards and Technology, Commerce. SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) that the National Institute of Standards and Technology (‘‘NIST’’), U.S. Department of Commerce, is contemplating the grant of an exclusive license in the United States of America, its territories, possessions and commonwealths, to NIST’s interest in the invention embodied in U.S. Patent No. 5,514,501 (Application No. 08/ 255,961), titled ‘‘Process For UVPhotopatterning of Thiolate Monolayers Self-Assembled On Gold, Silver and Other Substrates,’’ NIST Docket No. 93– 047US to Stratos Biosystems, LLC, having a place of business at 2401 Elliott Avenue, 5th Floor, Seattle, Washington 98121. The grant of the license would be for the field of use: Substrates for analysis of proteins and nucleic acids by mass spectrometry in the Life Sciences Research and In Vitro Diagnostic markets. FOR FURTHER INFORMATION CONTACT: J. Terry Lynch, National Institute of Standards and Technology, Office of Technology Partnerships, 100 Bureau Drive, Stop 2200, Gaithersburg, MD 20899, Phone 301–975–2691. SUPPLEMENTARY INFORMATION: The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty days from the date of this published Notice, NIST receives written evidence and argument which establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. The availability of the invention for licensing was published in the Federal Register on October 11, 1994. U.S. Patent No. 5,514,501 is owned by the U.S. government, as represented by the Secretary of Commerce. The invention is a process for creating a two dimensional spacial distribution pattern of ferent thiolate molecules on a substrate by illuminating a surface of a self-assembled monolayer of a first thiolate compound in the presence of oxygen with high frequency electromagnetic radiation distributed according to a desired pattern, and subsequently immersing the illuminated substrate in a solution of a second AGENCY: PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 thiolate compound so that molecules of the first thiolate compound in illuminated areas of the monolayer are exchanged for molecules of said second thiolate compound; and a patterned biomolecular composite formed of a substrate which forms a self-assembled thiolate monolayer when immersed in a solution of a thiolate forming compound, a thiolate monolayer deposited on the substrate and composed of patterned areas of first and second thiolate compounds, respectively, the first thiolate compound having an affinity for specifically or nonspecifically adsorbing a biological molecule, and the second thiolate compound having essentially no affinity for the biological molecule, and at least one biological material adsorbed in a corresponding pattern on the patterned areas of the first thiolate compound in the thiolate monolayer. Dated: March 9, 2007. James E. Hill, Acting Deputy Director. [FR Doc. E7–4865 Filed 3–15–07; 8:45 am] BILLING CODE 3510–13–P DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning a Method and Device for the Detection and Track of Targets in High Clutter Department of the Army, DoD. Notice. AGENCY: ACTION: SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention set forth in U.S. Patent No. 7,154,433 entitled ‘‘Method and Device for the Detection and Track of Targets in High Clutter,’’ issued on December 26, 2006. The United States Government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Office of Research and Technology Applications, SDMC– RDTC–TDL (Ms. Susan D. McRae), Bldg. 5220, Von Braun Complex, Redstone Arsenal, AL 35898. FOR FURTHER INFORMATION CONTACT: Ms. Joan Gilsdorf, Patent Attorney, e-mail: joan.gilsdorf@smdc.army.mil (256) 955– 3213 or Ms. Susan D. McRae, Office of Research and Technology Applications, e-mail: susan.mcrae@smdc.army.mil; (256) 955–1501. SUPPLEMENTARY INFORMATION: The invention pertains to Doppler radar systems for tracking targets in high E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 72, Number 51 (Friday, March 16, 2007)]
[Notices]
[Page 12596]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4865]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Institute of Standards and Technology


Notice of Prospective Grant of Exclusive Patent License

AGENCY: National Institute of Standards and Technology, Commerce.

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i) that the National Institute of Standards and 
Technology (``NIST''), U.S. Department of Commerce, is contemplating 
the grant of an exclusive license in the United States of America, its 
territories, possessions and commonwealths, to NIST's interest in the 
invention embodied in U.S. Patent No. 5,514,501 (Application No. 08/
255,961), titled ``Process For UV-Photopatterning of Thiolate 
Monolayers Self-Assembled On Gold, Silver and Other Substrates,'' NIST 
Docket No. 93-047US to Stratos Biosystems, LLC, having a place of 
business at 2401 Elliott Avenue, 5th Floor, Seattle, Washington 98121. 
The grant of the license would be for the field of use: Substrates for 
analysis of proteins and nucleic acids by mass spectrometry in the Life 
Sciences Research and In Vitro Diagnostic markets.

FOR FURTHER INFORMATION CONTACT: J. Terry Lynch, National Institute of 
Standards and Technology, Office of Technology Partnerships, 100 Bureau 
Drive, Stop 2200, Gaithersburg, MD 20899, Phone 301-975-2691.

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be 
royalty bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted unless, within thirty days from the date of this published 
Notice, NIST receives written evidence and argument which establish 
that the grant of the license would not be consistent with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7. The availability of the 
invention for licensing was published in the Federal Register on 
October 11, 1994.
    U.S. Patent No. 5,514,501 is owned by the U.S. government, as 
represented by the Secretary of Commerce. The invention is a process 
for creating a two dimensional spacial distribution pattern of ferent 
thiolate molecules on a substrate by illuminating a surface of a self-
assembled monolayer of a first thiolate compound in the presence of 
oxygen with high frequency electromagnetic radiation distributed 
according to a desired pattern, and subsequently immersing the 
illuminated substrate in a solution of a second thiolate compound so 
that molecules of the first thiolate compound in illuminated areas of 
the monolayer are exchanged for molecules of said second thiolate 
compound; and a patterned biomolecular composite formed of a substrate 
which forms a self-assembled thiolate monolayer when immersed in a 
solution of a thiolate forming compound, a thiolate monolayer deposited 
on the substrate and composed of patterned areas of first and second 
thiolate compounds, respectively, the first thiolate compound having an 
affinity for specifically or nonspecifically adsorbing a biological 
molecule, and the second thiolate compound having essentially no 
affinity for the biological molecule, and at least one biological 
material adsorbed in a corresponding pattern on the patterned areas of 
the first thiolate compound in the thiolate monolayer.

    Dated: March 9, 2007.
James E. Hill,
Acting Deputy Director.
[FR Doc. E7-4865 Filed 3-15-07; 8:45 am]
BILLING CODE 3510-13-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.